Title : Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model.

Pub. Date : 2019 Feb

PMID : 30821231






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Both cabozantinib and vandetanib demonstrated significantly better objective response rates and calcitonin (CTN) and carcinoembryonic antigen (CEA) response rates than placebo. vandetanib calcitonin related polypeptide alpha Homo sapiens
2 Both cabozantinib and vandetanib demonstrated significantly better objective response rates and calcitonin (CTN) and carcinoembryonic antigen (CEA) response rates than placebo. vandetanib calcitonin related polypeptide alpha Homo sapiens
3 Within the restricted EU-label population (symptomatic and progressive MTC with CEA/CTN doubling times of <= 24 months), the ICER for vandetanib is expected to be > $66,000 per QALY gained. vandetanib calcitonin related polypeptide alpha Homo sapiens